Menu Search
Equities

Intuitive Surgical Inc

ISRG:NSQ

Intuitive Surgical Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)550.62
  • Today's Change8.80 / 1.62%
  • Shares traded524.00
  • 1 Year change+76.58%
  • Beta1.3918
Data delayed at least 15 minutes, as of Nov 21 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy10
Outperform13
Hold9
Sell0
Strong Sell0

Share price forecast in USD

The 26 analysts offering 12 month price targets for Intuitive Surgical, Inc. have a median target of 548.50, with a high estimate of 643.00 and a low estimate of 443.00. The median estimate represents a -0.39% decrease from the last price of 550.62.
High16.8%643.00
Med-0.4%548.50
Low-19.5%443.00

Earnings history & estimates in USD

On Oct 17, 2024, Intuitive Surgical, Inc. reported 3rd quarter 2024 earnings of 1.84 per share. This result exceeded the 1.63 consensus of the 23 analysts covering the company and exceeded last year's 3rd quarter results by 26.03%.
The next earnings announcement is expected on Jan 21, 2025.
Average growth rate+6.34%
Intuitive Surgical, Inc. reported annual 2023 earnings of 5.71 per share on Jan 23, 2024.
Average growth rate+10.61%
More ▼

Revenue history & estimates in USD

Intuitive Surgical, Inc. had 3rd quarter 2024 revenues of 2.04bn. This bettered the 2.00bn consensus of the 23 analysts covering the company. This was 20.16% above the prior year's 3rd quarter results.
Average growth rate+4.09%
Intuitive Surgical, Inc. had revenues for the full year 2023 of 7.12bn. This was 14.49% above the prior year's results.
Average growth rate+12.95%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.